Show simple item record

Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent

dc.contributor.authorPalmer, Nicholette D.en_US
dc.contributor.authorMusani, Solomon K.en_US
dc.contributor.authorYerges‐armstrong, Laura M.en_US
dc.contributor.authorFeitosa, Mary F.en_US
dc.contributor.authorBielak, Lawrence F.en_US
dc.contributor.authorHernaez, Rubenen_US
dc.contributor.authorKahali, Bratatien_US
dc.contributor.authorCarr, J. Jeffreyen_US
dc.contributor.authorHarris, Tamara B.en_US
dc.contributor.authorJhun, Min A.en_US
dc.contributor.authorKardia, Sharon L.R.en_US
dc.contributor.authorLangefeld, Carl D.en_US
dc.contributor.authorMosley, Thomas H.en_US
dc.contributor.authorNorris, Jill M.en_US
dc.contributor.authorSmith, Albert V.en_US
dc.contributor.authorTaylor, Herman A.en_US
dc.contributor.authorWagenknecht, Lynne E.en_US
dc.contributor.authorLiu, Jiankangen_US
dc.contributor.authorBorecki, Ingrid B.en_US
dc.contributor.authorPeyser, Patricia A.en_US
dc.contributor.authorSpeliotes, Elizabeth K.en_US
dc.date.accessioned2013-09-04T17:18:16Z
dc.date.available2014-10-06T19:17:41Zen_US
dc.date.issued2013-09en_US
dc.identifier.citationPalmer, Nicholette D.; Musani, Solomon K.; Yerges‐armstrong, Laura M. ; Feitosa, Mary F.; Bielak, Lawrence F.; Hernaez, Ruben; Kahali, Bratati; Carr, J. Jeffrey; Harris, Tamara B.; Jhun, Min A.; Kardia, Sharon L.R.; Langefeld, Carl D.; Mosley, Thomas H.; Norris, Jill M.; Smith, Albert V.; Taylor, Herman A.; Wagenknecht, Lynne E.; Liu, Jiankang; Borecki, Ingrid B.; Peyser, Patricia A.; Speliotes, Elizabeth K. (2013). "Characterization of european ancestry nonalcoholic fatty liver diseaseâ associated variants in individuals of african and hispanic descent." Hepatology 58(3): 966-975. <http://hdl.handle.net/2027.42/99594>en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/99594
dc.publisherWiley Periodicals, Inc.en_US
dc.titleCharacterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descenten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23564467en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/99594/1/hep26440.pdf
dc.identifier.doi10.1002/hep.26440en_US
dc.identifier.sourceHepatologyen_US
dc.identifier.citedreferenceFBPP Investigators. Multi‐center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension 2002; 39: 3 ‐ 9.en_US
dc.identifier.citedreferenceBellentani S, Marino M. Epidemiology and natural history of non‐alcoholic fatty liver disease (NAFLD). Ann Hepatol 2009; 8 ( Suppl 1 ): S4 ‐ S8.en_US
dc.identifier.citedreferenceHarrison SA, Neuschwander‐Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 2004; 8: 861 ‐ 879, ix.en_US
dc.identifier.citedreferenceSpeliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979 ‐ 1987.en_US
dc.identifier.citedreferenceStepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 2012; 10: 646 ‐ 650.en_US
dc.identifier.citedreferenceAdams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population‐based cohort study. Gastroenterology 2005; 129: 113 ‐ 121.en_US
dc.identifier.citedreferenceSpeliotes EK, Yerges‐Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome‐wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7: e1001324.en_US
dc.identifier.citedreferenceLimanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276 ‐ 280.en_US
dc.identifier.citedreferenceKodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307 ‐ 1312.en_US
dc.identifier.citedreferenceBohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H‐MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta‐analysis. Eur Radiol 2011; 21: 87 ‐ 97.en_US
dc.identifier.citedreferenceHernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta‐analysis. Hepatology 2011; 54: 1082 ‐ 1090.en_US
dc.identifier.citedreferenceBrowning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387 ‐ 1395.en_US
dc.identifier.citedreferenceFan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005; 43: 508 ‐ 514.en_US
dc.identifier.citedreferenceMohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in non‐alcoholic fatty liver disease. J Hepatol 2009; 50: 797 ‐ 804.en_US
dc.identifier.citedreferenceDupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010; 42: 105 ‐ 116.en_US
dc.identifier.citedreferenceRomeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461 ‐ 1465.en_US
dc.identifier.citedreferenceFuqua SR, Wyatt SB, Andrew ME, Sarpong DF, Henderson FR, Cunningham MF, et al. Recruiting African American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 2005; 15: S6 ‐ 18‐29.en_US
dc.identifier.citedreferenceHenkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003; 13: 211 ‐ 217.en_US
dc.identifier.citedreferenceHamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708 ‐ 2715.en_US
dc.identifier.citedreferenceHiggins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143: 1219 ‐ 1228.en_US
dc.identifier.citedreferenceAlmasy L, Blangero J. Multipoint quantitative‐trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198 ‐ 1211.en_US
dc.identifier.citedreferenceSchwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009; 136: 1585 ‐ 1592.en_US
dc.identifier.citedreferenceWagenknecht LE, Scherzinger AL, Stamm ER, Hanley AJ, Norris JM, Chen YD, et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) 2009; 17: 1240 ‐ 1246.en_US
dc.identifier.citedreferenceHe S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706 ‐ 6715.en_US
dc.identifier.citedreferenceBeer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho‐Melander M, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009; 18: 4081 ‐ 4088.en_US
dc.identifier.citedreferenceHuang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem 2011; 286: 37085 ‐ 37093.en_US
dc.identifier.citedreferenceBasantani MK, Sitnick MT, Cai L, Brenner DS, Gardner NP, Li JZ, et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res 2011; 52: 318 ‐ 329.en_US
dc.identifier.citedreferenceRees MG, Wincovitch S, Schultz J, Waterstradt R, Beer NL, Baltrusch S, et al. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk. Diabetologia 2012; 55: 114 ‐ 122.en_US
dc.identifier.citedreferenceGraff M, North KE, Franceschini N, Reiner AP, Feitosa M, Carr JJ, et al. PNPLA3 gene‐by‐visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study. Int J Obes (Lond) 2013; 37: 432 ‐ 438.en_US
dc.identifier.citedreferenceWagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, Ziegler J, et al. Association of PNPLA3 with non‐alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011; 31: 412 ‐ 416.en_US
dc.identifier.citedreferenceSantoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, et al. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One 2012; 7: e37827.en_US
dc.identifier.citedreferenceKathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008; 358: 1240 ‐ 1249.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.